Braidwell LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Evolus, Inc. | $20.65M | 0.7% |
| BIOGEN INC. | $20.36M | 0.7% |
| ORTHOPEDIATRICS CORPKIDS | $19.54M | 0.6% |
| Tectonic Therapeutic, Inc.TECX | $19.35M | 0.6% |
| Ventyx Biosciences, Inc. | $17.34M | 0.6% |
| Zura Bio Limited | $16.67M | 0.5% |
| Compass Therapeutics, Inc. | $14.96M | 0.5% |
| Monte Rosa Therapeutics, Inc. | $14.87M | 0.5% |
| Harrow, Inc. | $14.47M | 0.5% |
| X4 Pharmaceuticals, Inc | $13.48M | 0.4% |
| REPLIGEN CORP | $13.40M | 0.4% |
| ICON plc | $13.37M | 0.4% |
| Kiniksa Pharmaceuticals International, plc | $12.95M | 0.4% |
| GRAIL, Inc. | $12.22M | 0.4% |
| Surrozen, Inc./DESRZN | $10.62M | 0.3% |
| Relmada Therapeutics, Inc. | $7.64M | 0.2% |
| Xencor Inc | $7.03M | 0.2% |
| Castle Biosciences, Inc. | $6.89M | 0.2% |
| Adaptive Biotechnologies Corp | $5.07M | 0.2% |
| BillionToOne, Inc.BLLN | $4.09M | 0.1% |
| Oruka Therapeutics, Inc. | $2.57M | 0.1% |
| Karyopharm Therapeutics Inc. | $2.23M | 0.1% |
| Pulmonx Corp | $1.66M | 0.1% |